Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor Survival

18 Jun 2021

Abstract excerpt

Background CD39 is one of the functional surface markers for T regulatory cells, the prognostic role and immune-related effects of CD39 in luminal breast cancer (BC) patients has not been evaluated yet. The aim of the current study was to explore the association between CD39 expression and clinic pathological characteristics and the prognosis in luminal BC patients. Methods Clinical information and RNA-sequencing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine and Purinergic Signaling
Share to CAR-T cell therapy research
Share to Tryptophan and brain disorders

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34220957
DOI: 10.3389/fgene.2021.682503

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Prognostic Biomarker of Luminal Breast Cancer: High CD39 Expression Is Related to Poor SurvivalPMID 34220957Read ↗

The prognostic value of CD39+CD8+ T cells as a potential surrogate marker of tumor-specific T cells in Asian triple-negative breast cancerSemantic proximity Read ↗

RBM39 is a potential prognostic biomarker associated with immune infiltrates in hepatocellular carcinomaSemantic proximity Read ↗

CD39 + tissue-resident memory CD8 + T cells with a clonal overlap across compartments mediate antitumor immunity in breast cancerSemantic proximity Read ↗

CD39 Identifies the CD4+ Tumor-Specific T-cell Population in Human CancerSemantic proximity Read ↗

Clinical Correlation of CD39 Expression on Killer T Cells in peripheral blood in Cervical Squamous Cell CarcinomaSemantic proximity Read ↗

Analysis of the prognostic significance of solute carrier (SLC) family 39 genes in breast cancer.Semantic proximity Read ↗

Comprehensive analysis reveals a prognostic and therapeutic biomarker CD3D in the breast carcinoma microenvironmentSemantic proximity Read ↗

CD39 <sup>+</sup> conventional CD4 <sup>+</sup> T cells with exhaustion traits and cytotoxic potential infiltrate tumors and expand upon CTLA-4 blockadeSemantic proximity Read ↗

Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancerSemantic proximity Read ↗

CD39 Identifies Tumor-Reactive CD8 T cells in Patients With Lung CancerSemantic proximity Read ↗

CLEC10A is A Prognostic Biomarker and is Correlated with Immune Infiltrates in Breast CancerSemantic proximity Read ↗

Expression of CD39 is associated with T cell exhaustion in ovarian cancer and its blockade reverts T cell dysfunctionSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.